from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun surgery The surgical procedure to remove plaque from an artery.


from Wiktionary, Creative Commons Attribution/Share-Alike License

atheroma +‎ -ectomy


  • Peripheral atherectomy, which is the largest product category within Vascular Intervention, is anticipated to grow 3% to 5%; this compares with previous guidance for growth of 11% to 13%.

    Spectranetics Reports Third Quarter Revenue of $29.6 Million - Yahoo! Finance

  • Supposedly the procedure offers better healing than either traditional angioplasty or directional atherectomy.

    Healing the Female Heart

  • Directional coronary atherectomy uses a cutting tool mounted on a catheter to shave the plaque off the blood vessel.

    Healing the Female Heart

  • Rotational atherectomy uses a tiny rotating tip, covered with thousands of microscopic diamond crystals, to whirr through the plaque.

    Healing the Female Heart

  • Some studies credit atherectomy with an 85 percent success rate.

    Healing the Female Heart

  • As we looked at that, there's actually some potential positive benefit around combination of PTA and atherectomy and there is a little bit of a change in reimbursement to kind of bump that in a positive direction.

  • ® PAD System and Diamondback Predator 360° ™ PAD System are percutaneous orbital atherectomy systems indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and stenotic material from artificial arteriovenous dialysis fistulae.

    Business Wire Travel News

  • As a result, our peripheral atherectomy business grew 14% sequentially and 6% year-over-year. Aktuelle Nachrichten

  • Vascular Intervention sales include three product lines - atherectomy (including peripheral and coronary), which increased 2%, crossing solutions, which decreased 1%, and thrombectomy, which increased 7%, all compared with the first quarter of 2009. Aktuelle Nachrichten

  • ABMD - News, a leading provider of breakthrough heart support technologies, today announced completion of the PROTECT II study¹ based on a futility determination at the planned interim analysis regarding the primary end-point, which the company views as likely to be due to unanticipated confounding variables related to the use of rotational atherectomy² in the study.

    Abiomed Ends Protect II Study and Announces Interim Results, Detailed Clinical Analysis to Be Presented at ACC 2011 - Yahoo! Finance


Log in or sign up to get involved in the conversation. It's quick and easy.